Louise Kooij

Louise Kooij

Chief Accounting OfficeratNewAmsterdam Pharma Co· In the 2025 proxy

Pay in FY2025NewAmsterdam Pharma Co stock +36.5% the same year

Louise Kooij was paid $2.2M in FY2025 (Dec). NewAmsterdam Pharma Co stock rose 36.5% that year.

Pay$100 in the stock at the end of FY24 → $136
Pay is from the Summary Compensation Table of each NewAmsterdam Pharma Co proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NewAmsterdam Pharma CoPublic company · 1 yr
    • Chief Accounting Officer2025 – Present · 1 yrStock in role -19%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?